Questions for the Consultant: Seizures and Epilepsy

Joseph I. Sirven; Richard S. Zimmerman

doi:10.1055/s-2003-814736

Seminars in Neurology, Inhaltsverzeichnis

Semin Neurol 2003; 23(3): 285-294
DOI: 10.1055/s-2003-814736

Questions for the Consultant: Seizures and Epilepsy

Joseph I. Sirven¹ , Richard S. Zimmerman²

¹Department of Neurology, Mayo Clinic, Scottsdale, Arizona
²Department of Neurosurgery, Mayo Clinic, Scottsdale, Arizona

Abstract

ABSTRACT

Issues regarding management of acute and chronic seizures constitute one of the more frequent consultations that all neurologists encounter. With a significant medical and surgical therapeutic armamentarium now available, many clinicians are perplexed about how to approach the most basic of seizure consultation questions. In this article, four of the most commonly asked seizure consultation questions are reviewed: when antiepileptic drug (AED) treatment should be initiated; how to choose an AED; when to refer a patient for surgery; and when to withdraw AEDs in a seizure-free patient. By utilizing frequently encountered clinical scenarios, the decision-making process to best illustrate application of existing clinical evidence to the individual patient is explored.

KEYWORDS

Seizure - antiepileptic drug therapy

Volltext

Referenzen

REFERENCES

1 Hauser W A, Hesdorffer D C. Epilepsy: Frequency, Causes, and Consequences. New York: Demos; 1990
2 Camfield P R, Camfield C S, Dooley J M. et al . Epilepsy after a first unprovoked seizure in childhood. Neurology . 1985; 35 1657-1660
3 Hopkins A, Garman A, Clarke C. The first seizure in adult life: value of clinical features, electroencephalography, and computerized tomographic scanning in prediction of seizure recurrence. Lancet . 1988; 1 21-26
4 Berg A T, Shinnar S. The risk of seizure recurrence following a first unprovoked seizure: a quantitative review. Neurology . 1991; 41 965-972
5 Shinnar S, Berg A T, Moshe S L. et al . Risk of seizure recurrence following a first unprovoked seizure in childhood: a prospective study. Pediatrics . 1990; 85 1076-1085
6 Annegers J F, Shirts S B, Hauser W A. et al . Risk of recurrence after an initial unprovoked seizure. Epilepsia . 1986; 27 43-50
7 Shinnar S, Berg A T, Moshe S L. et al . The risk of seizure recurrence after a first unprovoked afebrile seizure in childhood: an extended follow-up. Pediatrics . 1996; 98 216-225
8 Beghi E, Berg A, Hauser W. Treatment of single seizures. In: Engel J, Pedley T, eds. Epilepsy: A Comprehensive Textbook Philadelphia: Lippincott Williams & Wilkins 1998: 1285-1294
9 Gilad R, Lampl Y, Gabbay U. et al . Early treatment of a single generalized tonic-clonic seizure to prevent recurrence. Arch Neurol . 1996; 53 1149-1152
10 First Seizure Trial Group. Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic-clonic seizure. Neurology . 1993; 43 478-483
11 Camfield P R, Camfield C S, Dooley J S. et al . A randomized study of carbamazepine versus no medication after a first unprovoked seizure in childhood. Neurology . 1989; 39 851-852
12 Mattson R H, Cramer J A, Collins J F. et al . Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondary generalized tonic-clonic seizures. N Engl J Med . 1985; 313 145-151
13 Department of Veterans Affairs Epilepsy Cooperative Study Number 264 Group. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. N Engl J Med . 1992; 327 765-771
14 Theodore W H, Porter R J. Epilepsy: 100 Elementary Principles 3rd ed. Philadelphia: WB Saunders 1995
15 Sirven J. Acute and chronic seizures in the older adult. Mayo Clin Proc . 2001; 76 175-183
16 Cramer J A, Fisher R, Ben-Menachem E. et al . New antiepileptic drugs: a comparison of key clinical trials. Epilepsia . 1999; 40 590-600
17 Engel Jr J. Surgery for seizures. N Engl J Med . 1996; 334 647-652
18 Lamoureux D, Spencer S S. Epilepsy surgery in adults. Curr Opin Neurol . 1995; 8 107-111
19 Silfvenius H. Latest advances in epilepsy surgery. Acta Neurol Scand Suppl . 1995; 162 11-16
20 Sperling M R, O'Connor M J, Saykin A J. et al . Temporal lobectomy for refractory epilepsy. JAMA . 1996; 276 470-475
21 Sperling M R, Shewmon D A. General principles for presurgical evaluation. In: Engel J, Pedley T, eds. Epilepsy, a Comprehensive Textbook New York: Lippincott Williams & Wilkins 1998: 1697-1705
22 Kwan P, Brodie M J. Early identification of refractory epilepsy. N Engl J Med . 2000; 432 314-319
23 Dlugos D J, Samuel M D, Strom B L, Farrar J T. Response to first drug trial predicts outcome in childhood temporal lobe epilepsy. Neurology . 2001; 57 2259-2264
24 Wiebe S, Blume W T, Girvin J P. et al . Effectiveness of Surgery for Temporal Lobe Epilepsy Study Group. A randomized controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med . 2001; 345 311-318
25 Sperling M R, Saykin A J, Roberts D, French J A, O'Connor M J. Occupational outcome after temporal lobectomy for refractory epilepsy. Neurology . 1995; 45 970-977
26 Berg A T, Vickrey B G, Sperling M R. et al . Driving in adults with refractory localization-related epilepsy. Multi-center study of epilepsy surgery. Neurology . 2000; 54 625-630
27 Reeves A L, So E, Evans R W. et al . Factors associated with work outcome after anterior temporal lobectomy for intractable epilepsy. Epilepsia . 1997; 38 689-695
28 Carran M A, Kohler C G, O'Connor M J, Cloud B, Sperling M R. Marital status after epilepsy surgery. Epilepsia . 1999; 40 1755-1760
29 Sperling M R, Feldman H, Kinman J, Liporace J D, O'Connor M J. Seizure control and mortality in epilepsy. Ann Neurol . 1999; 46 45-50
30 Pilcher W H, Roberts D W, Flannigan H F. et al .Complications of epilepsy surgery. In: Engel J Jr, ed. Surgical Treatment of the Epilepsies 2nd ed. New York: Raven Press 1993: 565-581
31 Guldvog B, Loyning Y, Hangle-Hanssen E. et al . Surgical versus medical treatment for epilepsy I. Outcome related to survival, seizures, and neurological deficit. Epilepsia . 1991; 32 375-388
32 Medical Research Council Antiepileptic Drug Withdrawal Study Group. Randomised study of antiepileptic drug withdrawal in patients in remission. Lancet . 1991; 337 1175-1180
33 Callaghan N, Garrett A, Goggin T. Withdrawal of anticonvulsant drugs in patients free of seizures for two years. A prospective study. N Engl J Med . 1988; 318 942-946
34 Overweg J, Binnie C D, Oosting J, Rowan A J. Clinical and EEG prediction of seizure recurrence following antiepileptic drug withdrawal. Epilepsy Res . 1987; 1 272-283
35 Tinuper P, Avoni P, Riva R, Provini F, Lugaresi E, Baruzzi A. The prognostic value of the EEG in antiepileptic drug withdrawal in partial epilepsy. Neurology . 1996; 47 76-78
36 Uesiga H, Kojima T, Miyasaka M, Matsuura M, Ohtaka T, Moriiwa M. Discontinuation of antiepileptic drug treatment in controlled seizure patients. J Epilepsy . 1994; 7 178-188
37 Sirven J, Sperling M, Wingerchuk D. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission. Cochrane Database Syst Rev . 2001; 4
38 Chadwick D, Taylor J, Johnson T. Outcomes after seizure recurrence in people with well-controlled epilepsy and the factors that influence it. The MRC Antiepileptic Drug Withdrawal Group. Epilepsia . 1996; 37 1043-1050
39 Quality Standards Subcommittee of the American Academy of Neurology. Practice parameters; a guideline for discontinuing antiepileptic drugs in seizure-free patients. Neurology . 1996; 47 600-602
40 Berg A T, Shinnar S. Relapse following discontinuation of antiepileptic drugs: a meta analysis. Neurology . 1994; 44 601-608